Partnership optimises uniform processes
By recognition and early intervention against the most significant risk factors, many heart diseases can be prevented.
By recognition and early intervention against the most significant risk factors, many heart diseases can be prevented.
CardioSecur, a personalised mobile 12-lead ECG system with four electrodes for iPhone and iPad, enables patients to monitor their symptoms and transmit the data to their physicians in less than a minute.
Medical technology still is among the fastest growing industries worldwide. However, the growth of the demand volume even in emerging markets is less based on volume expansion but more driven by targeted investments in modern systems and procedures.
Carestream is receiving orders from healthcare providers around the world for its new Carestream Managed Print Solutions (MPS), a comprehensive, web-based, pay per print programme that tracks laser imaging film usage, and remotely monitors and delivers film inventory according to each facility’s needs. This comprehensive programme saves both time and money for healthcare providers.
The risk of terrorist attacks, nuclear-radiological hazards, power outages and epidemic-pandemic infections as well as earthquakes, hurricanes, tsunamis and fires are increasing worldwide. Mass casualty incidents, or MCIs, provide a constant reminder of why hospitals need a plan in place to be able to function optimally during and after a catastrophe.
The numbers of ‘suicide tourists’ going to Switzerland to take their own lives has doubled within the space of four years, reports a study published online in the Journal of Medical Ethics.
Acquisition to further industry innovation with a combined $650 million annual R&D investment Complementary client bases expand global presence.
Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus.
Whilst participants at the ‘Boundary-less Hospital in Health Care Networks’ conference, organised by the Centre for Advanced Studies in Management (CASiM) at Leipzig Graduate School of Management (HHL) in mid-June agreed on the need as such, there was plenty of room to discuss exactly which changes could make the German healthcare system future-ready.
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.
Even though a lot of us don’t do it, let’s say you know that washing your hands is the first, and the best thing, you can do to stop sharing nasty bugs that are especially dangerous for patients.
‘Better hygiene’ is the frequently and loudly recommended panacea in the intensifying struggle against hospital-acquired infections (HAIs). However there are currently no evidence-based studies that evaluate the efficacy of additional hygiene measures.
Free fertility treatment should be banned for those making "lifestyle" reproductive choices, such as sterilisation reversal or single motherhood for fertile women. And fertility clinics should be subject to carbon capping schemes, in a bid to help curb climate change, argues a bioethicist in the Journal of Medical Ethics.
According to the World Health Organisation (WHO), mental illness is associated with a significant burden of morbidity and disability.
Although nosocomial infections and medical accidents have declined, over 750 hospitals with the highest number of such cases now face penalties – amounting to an estimated $330 million a year – issued by Medicare.
Pointing out that it is unacceptable that some 300,000 people become adversely infected while being in the care of the UK’s National Health Service every year, the National Institute for Health and Care Excellence (NICE), which provides national guidance and advice to improve health and social care, has launched a new set of quality standards.
More than four million people acquire a healthcare associated infection (HAI) in the European Union (EU) annually; of these 37,000 die as a direct consequence of the infection, according to a European Centre for Disease Control 2008 estimate.
The UK’s first Specialist Emergency Care Hospital is on target to open for the first patients in 2015.
New cases and deaths attributable to Ebola virus disease (EVD) continue to be reported by the Ministries of Health in the three West African countries of Guinea, Liberia, and Sierra Leone.
“The Saudi Arabian government’s response to the new virulent Middle Eastern Respiratory Syndrome (MERS) has recently been criticized, following high-level dismissals within the Saudi state healthcare service. Criticism has been leveled at the slowness of the government’s response to the outbreak, as well as in-fighting between physicians", says Andrew Thompson, Ph.D., GlobalData’s…
Agfa HealthCare announces today that it has signed an agreement with Real Time Medical (RTM) to support the needs of collaborating or consolidated hospitals and imaging networks.
Conflict and crisis situations pose specific challenges for medical care. The only way to cope with them is to apply scientific evidence from an exchange between academic surgeons and their colleagues active in the field. The EFORT Congress in London is a crucial hub at European level for this exchange.
UK surgeons have to revalidate every five years to prove that they are still fit to practice. This example could be followed by other European countries, experts said at the 15th EFORT Congress in London. The European Federation of National Associations of Orthopaedics and Traumatology promotes a harmonisation of orthopaedic education in Europe.
Europe will now have just one international neurological association. The two European societies – the EFNS and the ENS – have merged during the Joint Congress of European Neurology in Istanbul to create the new European Academy of Neurology (EAN). Prof Günther Deuschl from Kiel, Germany, was elected the first President of the new organisation.
Finnish pharma company Orion and German healthcare giant Bayer have entered into an agreement for the development and commercialisation of a novel drug targeting prostate cancer.